Lenvatinib is a type I tyrosine kinase inhibitor that exhibits potent anti-angiogenic activity in cancer therapy. This product is a pre-formulated liposome encapsulating Lenvatinib. It is only for research purposes.
Lipid Composition
HSPC, Cholesterol
Encapsulated Drug
Lenvatinib
Buffer
CPBS, pH 3.0
Storage
Store in dark at +4°C and do not freeze
Size
100-200 nm
Quantity
5mL (available in lyophilized powder)
Dosage
Download
DataSheet
MSDS
Customer ReviewsRelated Sections
Click the button below to contact us or submit your feedback about this product.